AzTrials
AzTrials

Shoulder FracturesNCT06357143

Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis

A study testing REMOVE in people with Shoulder Fractures and Prosthesis User, run by University of Malaga at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The present study try to evaluate the effectivenness of an early intervention program based on multimodal physiotherapy and focused on therapeutic exercise to improve the results of patients with a reverse shoulder phrostesis. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Shoulder Fractures, Prosthesis User
What is being tested?
REMOVE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSpain
Study dates
1 Sep 2025to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults with a reverse shoulder prosthesis.
  • Age between 18 and 90 years.
  • Signed informed consent.

Who cannot join

  • Language or cultural barriers.
  • Other upper limb injury.
  • Treatment that affect physical activity capacity.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Antonio I Cuesta-Vargas, PhD contact

(+34) 667 45 55 44

acuesta@uma.es

Spain1 site, 1 recruiting
  • Antonio Cuesta Vargas

    Málaga

    Antonio Ignacio, Cuesta Vargas, PhD, 952137551 ext. +34, acuesta@uma.es

    Cuesta Vargas A Antonio Ignacio, PhD

    Recruiting

Other trials in Spain

About this study

Official title: Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis: a Randomized Controlled Trial.

The present study try to evaluate the effectivenness of an early intervention program based on multimodal physiotherapy and focused on therapeutic exercise to improve the results of patients with a reverse shoulder phrostesis. This trial will be a randomized controlled trial with parallel groups, and outcomes variables will include psychometric properties through the use of specific questionnaries, and laboratory variables such as strength with a dynamometer, range of movement with a goniometer, muscle mass with an ultrasound, and kinematic parameters with inertial sensors. This study aims to develop an original intervention program in order to try to establish new protocols in the management of these patients.

Read the detailed description

Background: Shoulder fractures, shoulder osteoarthritis and rheumatoid arthritis have a high prevalence and many times they require a surgery, in which a reverse shoulder phrostesis is colocated. Nonetheless, nowadays there is no a clear consensus protocol in order to manage the prehabilitation and rehabilitation of this patient, so each physiotherapist use different techniques to treat this pathology.

Objective: This study aims to evaluate the effectiveness of an original intervention program (REMOVE program) focused on an early intervention based on therapeutic exercise, manual therapy and education to improve the functionality of these patients after surgery.

Methods: This study is a randomized controlled trial with parallel groups. The control group receive standard care, and the experimental group is subjected to the REMOVE program. Both groups are evaluated five times, pre-surgery, at baseline, at 6 weeks, at 12 weeks and at 24 weeks to assess psychometric and laboratory outcomes.

Being tested
REMOVE, CONTROL
Medical subject headings
Shoulder Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • REMOVEOther

    INITIAL STAGE:

    • Aim: Recover mobility
    • Exercises: Passive therapy, isometric exercises focused on middle deltoid.
    • Goal: 80º passive flexion, 45º abduction, 5 N of abduction force STRENGTHENING STAGE
    • Aim: Enhance scapulohumeral rhythm and strength rotator cura
    • Exercises: Active-assisted therapy, isotonic exercises between 45-90º of forward flexión and abduction with dumbbells and isometric exercises focused on internal and external rotation.
    • Goal: 100º passive flexion, 90º lateral abduction, 10 N of abduction force INTENSIVE STAGE
    • Aim: Improve motor control and increase cross-sectional muscular área
    • Exercises: Rowe with resistance band, wall push ups, lateral elevation with dumbbles, active external and internal rotation.
    • Goal: 15 N of abduction force FUNCTIONAL STAGE
    • Aim: Develope daily life activities
    • Exercises: Overhead tasks, rowe with Kettlebell, internal and external rotations with resistance bands
    • Goal: 20 N of abduction force
  • CONTROLOther

    Patients will undergo standard care which consists of an initial consultation with the physiotherapist to receive some recommendations about exercises, progression and health education

Study groups in NCT06357143
Study groupRoleWhat they receive
CONTROL GROUP - STANDARD PHYSIOTHERAPYActive comparatorPatients will undergo standard care which consists of an initial consultation with the physiotherapist to receive some recommendations about exercises, progression and health education
Receives: Other: CONTROL
EXPERIMENTAL GROUP - REMOVE PROGRAMExperimentalINITIAL STAGE: * Aim: Recover mobility * Exercises: Passive therapy, isometric exercises focused on middle deltoid. * Goal: 80º passive flexion, 45º abduction, 5 N of abduction force STRENGTHENING STAGE * Aim: Enhance scapulohumeral rhythm and strength rotator cura * Exercises: Active-assisted therapy, isotonic exercises between 45-90º of forward flexión and abduction with dumbbells and isometric exercises focused on internal and external rotation. * Goal: 100º passive flexion, 90º lateral abduction, 10 N of abduction force INTENSIVE STAGE * Aim: Improve motor control and increase cross-sectional muscular área * Exercises: Rowe with resistance band, wall push ups, lateral elevation with dumbbles, active external and internal rotation. * Goal: 15 N of abduction force FUNCTIONAL STAGE * Aim: Develope daily life activities * Exercises: Overhead tasks, rowe with Kettlebell, internal and external rotations with resistance bands * Goal: 20 N of abduction force
Receives: Other: REMOVE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. American Shoulder and Elbow Surgeons Scale (ASES) - Functionality.

    This tool is used to evaluate functionality and shoulder-related problems. This scale contains demographic data, medical evaluation, and self-reported outcomes, with a visual analog scale (VAS) to report pain, and 10 items regarding daily life activities.

    The score is calculated: [(10 - score obtained in VAS) x 5] + (5/3 x score obtained in daily life activities)]. The worst result is 0 points and the best one is 100 points.

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

Secondary outcomes (9)
  1. Ultrasound image - Muscle thickness in centimeters.

    To measure the thickness of lateral deltoid muscle at rest, at maximum contraction, and fatigued, being able to compare the muscle mass variation between presurgical and postsurgical situation, and the effect of the intervention in this variable.

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

  2. Inertial sensors - Linear acceleration and angular velocity

    To assess kinematics variables such as angular velocity and linear acceleration during flexion, abduction and scaption, to evaluate the scapulohumeral rhythm and the tridimensional scapula motion.

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

  3. Dynamometer - Strength in Newtons.

    To measure strength, time to peak, rate of force development, and muscle power of the lateral deltoid.

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

  4. Goniometer - Range of motion in degrees.

    To measure the range of motion, both passive and active, in flexion, abduction, external rotation and internal rotation.

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

  5. Constant-Murley Score (CS) - Functionality

    To evaluate functional status of the shoulder. The scale is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion (40 points).

    The total score is between 0 points (worst result) and 100 points (best result).

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

  6. University of California - Los Angeles Shoulder Scale (UCLA) - Functionality.

    To assess functional outcomes after shoulder interventions. The scale include five categories: active forward flexion (5 points), strength of forward flexion (5 points), pain (10 points), satisfaction (5 points), and function (10 points).

    The total score range from 0 points (worst result) and 35 points (best result).

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

  7. Simple Shoulder Test (SST) - Functionality.

    To evaluate the ability of the affected shoulder to perform daily live activities.

    The tool is based on 12 "yes" (1 point) or "no" (0 points) questions. Overall score is calculated by: [number of "yes" / number of completex items] x 100, were 0 % is the worst result, and 100% is the best result.

    Measured: BASELINE, 12 WEEKS, 24 WEEKS

  8. Physiological fatigue - high density electromyography

    We are going to use a matrix of 64 electrodes located on middle deltoid muscle. The variables extracted will be: impulse train, motor neuron recruitment,, neural drive speed

    Measured: Baseline, 6 Weeks, 12 weeks, 24 weeks.

  9. Kinematics - Motion capture system

    We are going to record analytical movements (forward flexion, lateral abduction, scaption) and functional movements with a mobile phone camera, to analyze position, linear acceleration and angular velocity

    Measured: Baseline, 6 weeks, 12 weeks, 24 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2024
  2. Study start1 Sep 2025
  3. Primary completionJun 2026 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06357143
Sponsor's protocol ID
REMOVE
Status last verified
Apr 2026
First submitted
4 Apr 2024
Last updated
8 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing REMOVE in people with Shoulder Fractures and Prosthesis User, run by University of Malaga at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Antonio I Cuesta-Vargas, PhD ((+34) 667 45 55 44, acuesta@uma.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

American Shoulder and Elbow Surgeons Scale (ASES) - Functionality. (time frame: BASELINE, 12 WEEKS, 24 WEEKS). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in